Thiol-activated cytolysins

Reviews and Research in Medical Microbiology

Volumn 7, Issue 4, 1996, Pages 221-229

  Morgan, P J ^a   Andrew, P W ^a   Mitchell, T J ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Listeriolysin; Membrane damaging toxin; Perfringolysin; Pneumolysin; Streptolysin; Thiol activated cytolysin; Thiol activated toxin

Indexed keywords

BACTERIAL TOXIN; BINDING PROTEIN; CHOLESTEROL; CYTOLYSIN; THIOL;

BACTERIAL INFECTION; CELL FUNCTION; CELL MEMBRANE; COMPLEMENT ACTIVATION; GRAM NEGATIVE BACTERIUM; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TOXIN ANALYSIS; TOXIN STRUCTURE;

EID: 0029852034     PISSN: 0954139X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00013542-199610000-00004     Document Type: Review

References (50)

1. Korchev YE, Bashford CL, Pasternak CA. Differential sensitivity of pneumolysin-induced channels to gating by divalent cations. J Memb Biol 1992; 127: 195-203.
2. Haas A, Dumbsky M, Kreft J. Listeriolysin genes: complete sequence of ivanolysin from Listeria ivanovii and of listeriolysin from Listeria seeligeri. Biochim Biophys Act 1992; 1130: 81-84.
3. Hugo F, Reichwein J, Arvand M, Kramer S, Bhakdi S. Use of a monoclonal antibody to determine the mode of transmembrane pore-formation by streptolysin O. Infect Immun 1986; 54: 641-645.
4. de los Toyos JR, Mendez FJ, Aparicio JF et al. Functional analysis of pneumolysin by use of monoclonal antibodies. Infect Immun 1996; 64: 480-484.
5. Alouf JE, Geoffroy C. The family of antigenically-related, cholesterol-binding ('sulphydryl-activated') cytolytic toxins. In: Alouf JE, Freer JH, eds. Sourcebook of bacterial protein toxins. London: Academic Press, 1992, pp 147-186.
6. Nakamura M, Sekino N, Iwamoto M, Ohno-Iwashita Y. Interaction of theta-toxin (perfringolysin O), a cholesterol-binding cytolysin, with liposomal membranes: change in the aromatic side chains upon binding and insertion. Biochem 1995; 34: 6513-6520.
7. Saunders FK, Mitchell TJ, Walker JA, Andrew PW, Boulnois GJ. Pneumolysin, the thiol-activated toxin of Streptococcus pneumoniae, does not require a thiol group for in vitro activity. Infect Immun 1989; 57: 2547-2552.
8. Paton JC, Ferrante A. Inhibition of human polymorphonuclear leukocyte respiratory burst, bactericidal activity, and migration by pneumolysin. Infect Immun 1983; 41: 1212-1216.
9. Nandoskar M, Ferrante A, Bates EJ et al. Inhibition of human monocyte respiratory burst, degranulation, phospholipid methylation and bactericidal activity by pneumolysin. Immunol 1986; 59: 515-520.
10. Houldsworth S, Andrew PW, Mitchell TJ. Pneumolysin stimulates production of tumor necrosis factor alpha and interleukin-1-beta by human mononuclear phagocytes. Infect Immun 1994; 62: 1501-1503.
11. Rubins JB, Mitchell TJ, Andrew PW, Niewoehner DE. Pneumolysin activates phospholipase A in pulmonary artery endothelial cells. Infect Immun 1994; 62: 3829-3836.
12. Feldman C, Mitchell TJ, Andrew PW et al. The effect of Streptococcus pneumoniae pneumolysin on human respiratory epithelium in vitro. Microb Path 1990; 9: 275-284.
13. Paton JC, Rowan KB, Ferrante A. Activation of human complement by the pneumococcal toxin pneumolysin. Infect Immun 1984; 43: 1085-1087.
14. Bhakdi S, Tranum-Jensen J. Complement activation and attack on autologous cell membranes induced by Streptolysin-O. Infect Immun 1985; 48: 713-719.
15. Mitchell TJ, Andrew PW, Saunders FK, Smith AN, Boulnois GJ. Complement activation and antibody binding by pneumolysin via a region of the toxin homologous to a human acute-phase protein. Mol Microbiol 1991; 5: 1883-1888.
16. Portnoy DA, Jacks PS, Hinrichs DJ. Role of hemolysin for the intracellular growth of Listeria monocytogenes. J Exp Med 1988; 167: 1459-1471.
17. Tilney LG, Portnoy DA. Actin filaments and the growth, movement and spread of the intracellular bacterial parasite, Listeria monocytogenes. J Cell Biol 1989; 109: 1597-1608.
18. Bielecki J, Youngman P, Connelly P, Portnoy DA. Bacillus subtilis expressing a haemolysin gene from Listeria monocytogenes can grow in mammalian cells. Nature 1990; 345: 175-176.
19. Yoshikawa H, Kawamura I, Fujita M, Tsukada H, Arakawa M, Mitsuyama M. Membrane damage and interleukin-1 production in murine macrophages exposed to listeriolysin O. Infect Immun 1993; 61: 1334-1339.
20. Berry AM, Yother J, Briles DE, Hansman D, Paton JC. Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae. Infect Immun 1989; 57: 2037-2042.
21. Canvin JR, Marvin AP, Sivakumaran M et al. The role of pneumolysin and autolysin in the pathology of pneumonia and septicemia in mice infected with a type 2 pneumococcus. J Infect Dis 1995; 172: 119-123.
22. Feldman C, Munro NC, Jeffrey DK et al. Pneumolysin induces the salient features of pneumococcal infection in the rat lung in vivo. Am J Resp Cell Mol Biol 1991; 5: 416-423.
23. Berry AM, Alexander JE, Mitchell TJ, Andrew PW, Hansman D, Paton JC. Effect of defined point mutations in the pneumolysin gene on the virulence of Streptococcus pneumoniae. Infect Immun 1995; 63: 1969-1974.
24. Rubins JB, Charboneau D, Fasching C et al. Distinct role for pneumolysin's cytotoxic and complement activities in the pathogenesis of pneumococcal pneumonia. Am J Respir Crit Care Med 1996 (in press).
25. Awad MM, Bryant AE, Stevens DL, Rood JI. Virulence studies on chromosomal alpha-toxin and theta-toxin mutants constructed by allelic exchange provide genetic-evidence for the essential role of alpha-toxin in Clostridium perfringens-mediated gas-gangrene. Mol Microbiol 1995; 15: 191-202.
26. Kehoe MA, Miller L, Walker JA, Boulnois GJ. Nucleotide sequence of the streptolysin O (SLO) gene: structural homologies between SLO and other membrane-damaging, thiol-activated toxins. Infect Immun 1987; 55: 3228-3232.
27. Iwamoto M, Ohno-Iwashita Y, Ando S. Role of the essential thiol group in the thiol-activated cytolysin from Clostridium perfringens. Eur J Biochem 1987; 167: 425-430.
28. Alouf JE. Les toxins cytolytiques bacteriennes thiol-dependantes: streptolysine O et toxines apparentees. Thiol-dependent cytolytic bacterial toxins: streptolysin O and related toxins. Arch Inst Pasteur (Tunis) 1981; 355-373.
29. Mitchell TJ, Andrew PW, Boulnois GJ, Lee C-J, Lock RA, Paton JC. Molecular studies of pneumolysin, the thiol-activated toxin of Streptococcus pneumoniae as an aid to vaccine design. In: Bacterial protein toxins. Gustav Fischer, Stuttgart: 1992, pp 429-437.
30. Owen RHG, Boulnois GJ, Andrew PW, Mitchell TJ. A role in cell-binding for the C-terminus of pneumolysin, the thiol-activated toxin of Streptococcus pneumoniae. FEMS Microbiol Lett 1994; 121: 217-222.
31. Iwamoto M, Ohno-Iwashita Y, Ando S. Effect of isolated C-terminal fragment of theta-toxin (perfringolysin O) on toxin assembly and membrane lysis. Eur J Biochem 1990; 194: 25-31.
32. Tweten RK. Nucleotide sequence of the gene for perfringolysin O (theta-toxin) from Clostridium perfringens: significant homology with the genes for streptolysin O and pneumolysin. Infect Immun 1988; 56: 3235-3240.
33. Parker MW, van der Goot FG, Buckley JT. Aerolysin - the ins and cuts of a model channel-forming toxin. Mol Microbiol 1996; 19: 205-212.
34. Morgan PJ, Varley PG, Rowe AJ, Andrew PW, Mitchell TJ. Characterization of the solution properties and conformation of pneumolysin, the membrane-damaging toxin of Streptococcus pneumoniae. Biochem J 1993; 296: 671-674.
35. Morgan PJ, Hyman SC, Byron O, Andrew PW, Mitchell TJ, Rowe AJ. Modeling the bacterial protein toxin, pneumolysin, in its monomeric and oligomeric form. J Biol Chem 1994; 269: 25315-25320.
36. Sowdhamini R, Mitchell TJ, Andrew PA, Morgan PJ. Structural and functional analogy between pneumolysin and pnaerolysin. Protein Engineering 1996; 9 (in press).
37. Duncan JL, Schlegel R. Effect of streptolysin O on erythrocyte membranes, liposomes and lipid dispersions. J Cell Biol 1975; 67: 160-173.
38. Olofsson A, Hebert H, Thelestam M. The projection structure of perfringolysin O (Clostridium perfringens theta-toxin). FEBS Lett 1993; 319: 125-127.
39. Sekiya K, Satoh R, Danbara H, Futaesaku Y. A ring-shaped structure with a crown formed by streptolysin O on the erythrocyte membrane. J Bacteriol 1993; 175: 5953-5961.
40. Morgan PJ, Hyman SC, Rowe AJ, Mitchell TJ, Andrew PW, Saibil HR. Subunit organisation and symmetry of pore-forming oligomeric pneumolysin. FEBS Lett 1995; 371: 77-80.
41. Bhakdi S, Weller U, Walev I, Martin E, Jonas D, Palmer M. A guide to the use of pore-forming toxins for controlled permeabilisation of cell membranes. Med Microbiol Immunol (Berl) 1993; 182: 167-175.
42. Gottschalk S, Tweten RK, Smith LC, Woo SLC. Efficient gene delivery and expression in mammalian cells using DNA coupled with perfringolysin O. Gene Therapy 1995; 2: 498-503.
43. Drobniewski FA, Watson GJ, Wawrzynczak EJ, Alouf JE, Thorpe PE. A novel membrane-acting immunotoxin, the immunolysin, with therapeutic potential. Biochem Soc Trans 1992; 20: 318.
44. Paton JC, Lock RA, Hansman DJ. Effect of immunization with pneumolysin on survival time of mice challenged with Streptococcus pneumoniae. Infect Immun 1983; 40: 548-552.
45. Alexander JE, Lock RA, Peeters C et al. Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae. Infect Immun 1994; 62: 5683-5688.
46. Walker JA, Allen RL, Falmagne P et al. Molecular cloning, characterization, and complete nucleotide sequence of the gene for pneumolysin, the sulfhydryl-activated toxin of Streptococcus pneumoniae. Infect. Immun. 1987; 55: 1184-1189.
47. Mengaud J, Vicente MF, Chenevert J et al. Expression of Escherichia coli and sequence analysis of the listeriolysin O determinant of Listeria monocytogenes. Infect Immun 1988; 56: 766-772.
48. Kreft J, Berger H, Hartlein M, Muller B, Weidinger G, Goebel W. Cloning and expression in Escherichia coli and Bacillus subtilis of the hemolysin (cereolysin) determinant from Bacillus cereus. J Bacteriol 1983; 155: 681-689.
49. Yutsudo T. Amino acid sequence of cereolysin (derived from nucleotide sequence PID: g600252). GENBANK ACCESSION: D21270 1994.
50. Geoffroy C, Mengaud J, Alouf JE, Cossart P. Alveolysin, the thiol-activated toxin of Bacillus alvei, is homologous to listeriolysin O, perfringolysin O, pneumolysin, and streptolysin O and contains a single cysteine. J Bacteriol 1990; 172: 7301-7305.